| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Hopman Mark is a Chief Commercial Officer at Beta Bionics, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $298K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | BBNX Beta Bionics, Inc. | Chief Commercial Officer | Sale+OE | 18,229 | $20.34 | $370,836.95 | -22.6% | +48.5% | - | |
| Sep 2, 2025 | BBNX Beta Bionics, Inc. | Chief Commercial Officer | Sell | 848 | $18.86 | $15,995.99 | -2.5% | +55.3% | - | |
| Aug 19, 2025 | BBNX Beta Bionics, Inc. | Chief Commercial Officer | Sale+OE | 16,158 | $16.61 | $268,376.30 | -32.1% | +71.0% | - | |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | Chief Commercial Officer | Sell | 868 | $17.89 | $15,529.30 | -0.8% | +1.8% | - |